Millions of Britons with an undiagnosed sleep condition which dramatically raises the risk of heart attacks and strokes could soon benefit from a revolutionary gadget. The small device, called ...

A GOOD night’s sleep isn’t a given, especially if you suffer from sleep apnoea – a condition where one’s breathing stops and starts several times during sleep, leaving one fatigued during the day even ...

People living in areas of elevated air pollution may be at risk of more serious sleep apnea events, according to a large new study that spans multiple countries. However, being aware of your air ...

Discover the calming power of 432Hz Healing Frequency music, designed to guide you into a state of deep sleep. This soothing audio journey promotes relaxation, reduces stress, and enhances your ...

This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 3 minutes It used to be easy to make ...

Currently, many people diagnosed with OSA patients require a machine that covers their nose or both the nose and mouth during sleep and delivers air through a mask to help keep their airways open.

Yaqoot Fatima receives funding from NHMRC, MRFF, Beyond Blue and in-kind support from ResMed. Nisreen Aouira does not work for, consult, own shares in or receive funding from any company or ...

OSA affects about 1 in 5 adults and increases the risk of heart disease and diabetes. Home sleep apnea tests (HSAT) offer accessible and cost-effective diagnosis. CPAP remains the gold standard, but ...

You know that a lack of sleep can hurt your heart. But if, like 30 million other Americans, you have sleep apnea, you could be getting plenty of zzz’s and still be putting your heart at risk. We asked ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The ...

The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision makes it ...